Jeannie Umanzor
Psychiatric/Mental Health · van Nuys, CANPI 1992234165
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $13,009 of the $17,058 with a category attached, or 76.3%. 13 manufacturers reported payments, led by Teva Pharmaceuticals USA, Inc. at 56.4% of the total. 2025 is the largest year on record at $9,624, more than ten times the $279 reported in 2022. Among psychiatric/mental health clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 166 payments — averaging $102.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$10K
- Otsuka America Pharmaceutical, Inc.$6K
- Lundbeck LLC$577
- Alkermes, Inc.$300
- AbbVie$125
- Viiv Healthcare Company$119
- plus $353 from 7 others
What the payments were for
- Speaking & faculty fees$13,00976%
- Travel & lodging$9185%
- Food & beverage$2,99818%
- Education$1321%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 71 | $9,626 |
| Otsuka America Pharmaceutical, Inc. | 18 | $5,957 |
| Lundbeck LLC | 44 | $577 |
| Alkermes, Inc. | 13 | $300 |
| AbbVie | 5 | $125 |
| Viiv Healthcare Company | 1 | $119 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 2 | $83 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $68 |
| Hikma Pharmaceuticals USA | 3 | $57 |
| Sunovion Pharmaceuticals Inc. | 2 | $48 |
| E.r. Squibb & Sons, L.L.C. | 2 | $43 |
| Indivior Inc. | 1 | $35 |
| Gilead | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- UZEDY$7,932
- ABILIFY MAINTENA$5,809
- ABILIFY ASIMTUFII$5,809
- Austedo XR$115
How this compares
$17,058 in reported general payments places this provider in the 95th percentile of 2,433 psychiatric/mental health providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxazepam | 13 | $2,758 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 14 | $2,382 |
| Bupropion Hcl | 13 | $330 |
| Aripiprazole | 16 | $262 |
| Mirtazapine | 13 | $213 |
| Quetiapine Fumarate | 30 | $190 |
| Bupropion XlBupropion Hcl | 16 | $174 |
| Benztropine Mesylate | 15 | $112 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Hikma Pharmaceuticals USABuprenorphine-Naloxone | $57 | $2,38214 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,433 psychiatric/mental health providers in California.
Other psychiatric/mental health in van Nuys
- Carey MartinMillbrae$745K
- Liberty MaciasRedlands$288K
- Joshua BurgettSacramento$239K
- Jovita Ezirim-SalamialofojeLos Angeles$162K
- Angie-Kolleen TanThousand Oaks$159K
- Thy LamVista$121K
- Samantha PerkinsAnaheim$49K
- Yvette ElpidioOrange$43K
- Sarah KoLos Angeles$34K
- Jonathan LlamasPasadena$31K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.